1. |
Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med, 2006, 354(8): 841-848.
|
2. |
Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage, 2010, 18(4): 476-499.
|
3. |
Mcalindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. IEEE Trans Aerosp Electron Syst, 2014, 22(3): 363-388.
|
4. |
Rutjes A, Jüni P, Costa B, et al. Viscosupplementation for Osteoarthritis of the Knee: A Systematic Review and Meta-analysis. Ann Intern Med, 2012, 157(3): 180-191.
|
5. |
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration. 2011. Available at: www.cochrane-handbook.org.
|
6. |
Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol, 1998, 25(25): 2203-2212.
|
7. |
Altman RD, Rosen JE, Bloch DA, et al. A Double-Blind, Randomized, Saline-Controlled Study of the Efficacy and Safety of EUFLEXXA ®, for Treatment of Painful Osteoarthritis of the Knee, With an Open-Label Safety Extension (The FLEXX Trial). Semin Arthritis Rheum, 2009, 39(1): 1-9.
|
8. |
Arden NK, Åkermark C, Andersson M, et al. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis. Curr Med Res Opin, 2014, 30(2): 279-286.
|
9. |
Baltzer A, Moser C, Jansen SA, et al. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage, 2008, 17(2): 152-160.
|
10. |
Chevalier X, Jerosch J, Goupille P, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis, 2010, 69(1): 113-119.
|
11. |
Day R, Brooks P, Conaghan PG, et al. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol, 2004, 31(4): 775-782.
|
12. |
Huang TL, Chang CC, Lee CH, et al. Intra-articular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the asian population. BMC Musculoskelet Disord, 2011, 12(1): 221-221.
|
13. |
Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology, 1999, 38(7): 602-607.
|
14. |
Jubb RW, Piva S, Beinat L, et al. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract, 2003, 57(6): 467-474.
|
15. |
Karlsson J, Sjögren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology, 2002, 41(11): 1240-1248.
|
16. |
Lundsgaard C, Dufour N, Fallentin E, et al. Intra-articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol, 2008, 37(2): 142-150.
|
17. |
Neustadt D, Caldwell J, Bell M, et al. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol, 2005, 32(10): 1928-1936.
|
18. |
Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intra-articular hyaluronic acid for osteoarthritis of the knee. J Rheumatol, 2006, 33(5): 951-956.
|
19. |
Pham T, Henanff AL, Ravaud P, et al. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis, 2004, 63(12): 1611-1617.
|
20. |
Strand V, Baraf HS, Lavin PT, et al. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthritis Cartilage, 2012, 20(5): 350-356.
|
21. |
Weegen WV, Wullems JA, Bos E, et al. No Difference Between Intra-Articular Injection of Hyaluronic Acid and Placebo for Mild to Moderate Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial. J Arthroplasty, 2014, 30(5): 754-757.
|
22. |
Zhang Q, Zhang T. Effect on Pain and Symptoms of Aspiration Before Hyaluronan Injection for Knee Osteoarthritis: A Prospective, Randomized, Single-blind Study. Am J Phys Med, 2015, 1977(260): 1-15.
|
23. |
Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol, 1974, 22(8): 731-736.
|
24. |
Altman RD, Schemitsch E, Bedi A. Assessment of Clinical Practice Guideline Methodology for the Treatment of Knee Osteoarthritis with Intra-Articular Hyaluronic Acid. Semin Arthritis Rheum, 2015, 45(2): 132-139.
|
25. |
Reid MC. Viscosupplementation for osteoarthritis: a primer for primary care physicians. Adv Ther, 2013, 30(11): 967-986.
|
26. |
Migliore A, Granata M. Intra-articular use of hyaluronic acid in the treatment of osteoarthritis. Clin Interv Aging, 2008, 3(2): 365-369.
|
27. |
Wang F, Xijing HE. Intra-articular hyaluronic acid and corticosteroids in the treatment of knee osteoarthritis: A meta-analysis. Exp Ther Med, 2015, 9(2): 493-500.
|